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We have demonstrated that IFN-7, a potent peptide mediator in inflammatory esponses, operates via the protein kinase 
C dependent transduction pathway in the induction of class II MHC antigens on rat microvascular endothelial cells. 
Stimulators of protein kinase C, like PMA, replaced IFN-~, in the induction of MHC class II on endothelial cells in a 
dose-dependent manner. Selective nzyme inhibitors of protein kinase C, H-7 as well as sphingosine down-regulated the 
IFN- 7 induced class II expression i a dose-dependent manner. Addition of cAMP or cGMP in the culture, had no effect 
on the class II expression on the endothelial cells. Transient rise of cytosolic Ca 2÷ by calcium ionophore A23187, or a 
calmodulin antagonist W-7, had no effect on the IFN-7 induced class II expression. 
Interferon-7; Protein kinase C; Major histocompatibility complex class II induction 
1. INTRODUCTION 
Class II antigens are encoded by genes in the ma- 
jor histocompatibility complex (MHC) and func- 
tion as restriction elements in immune reactions. 
Class II antigens are constitutively expressed on 
many cells, like macrophages and B ceils, and can 
be induced onto many cells like T cells, fibroblasts 
and endothelial ceils. Interferon-gamma (IFN- 7) 
has a broad variety of biological functions. Among 
other properties it increases class II MHC antigens 
of the major histocompatibility complex in many 
different cell types [1]. Endothelial cells are in 
native state negative for class II antigens, but begin 
to express these antigens 24 h after initiation of 
IFN- 7 treatment [2,3]. This IFN-7" effect has been 
shown to trigger de novo RNA and protein syn- 
thesis [4]. 
Phosphatidylinositol diphosphate (PIP2) is 
hydrolysed to inositoltriphosphate (IP3) and 
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diacylglycerol (DAG), the latter being a stimulator 
of protein kinase C [5,6]. Protein kinase C is an in- 
tracellular signal transduction pathway activated 
endogenously by diacylglycerol. Phorbol 
12-myristate 13-acetate (PMA) stimulation of pro- 
tein kinase C, appears to be due to the same 
mechanism as that of diacylglycerol, i.e., a 
decrease in the Km of the enzyme for Ca 2+ [7,8]. 
Thus phorbol esters mimick the endogenous 
stimulus of protein kinase C and can be used to 
study the effects of protein kinase C. The only 
drawback is that the phorbol esters also have many 
functions other than protein kinase C activation. 
We analysed the intracellular second messenger 
pathway in the regulation of class II antigens on 
rat microvascular endothelial cells. Our results 
show that IFN-7 induced class II expression on en- 
dothelial cells can be down-regulated with specific 
inhibitors of protein kinase C. Direct stimulation 
of protein kinase C with PMA leads to similar in- 
crease in class II expression on endothelial cells as 
does IFN-7. Increase in cytosolic Ca 2÷ by calcium 
ionophore A23187, or other intracellular second 
messengers like cyclic adenosine monophosphate 
(cAMP) and cyclic guanosine monophosphate 
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(cGMP) ,  had  no  ef fect  o f  the  class II express ion  on  
the  endothe l ia l  cells. 
2. MATERIALS  AND METHODS 
4-12-day-old DA rats were used. A modification of the 
method of Kasten [1,9] was used. In some experiments the cells 
growing in T-25 flasks were stimulated with 100 U/ml recombi- 
nant rat IFN- 7 for 24 h (a gift from Dr P .H.v .d .  Meide, 
Rijswijk, The Netherlands). In other experiments endothelial 
ceils growing in flasks were treated for 24 h with N6-2'-O - 
dibutyryladenosine 3' : 5'-cyclic monophosphate (cAMP, 
1/zM- 1 mM), N2-2 ' -O-dibutyrylguanosine 3' : 5' -cyclic 
monophosphate (cGMP, 1/~M-1 raM), calcium ionophore 
A23187 (20 nM-I/~M) and phorbol 12-myristate 13-acetate 
(PMA, 0.1-1/zM) (all purchased from Sigma, St. Louis, USA). 
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Fig. 1. IFN- 7 induction of class II molecules on endothelial cells. Endothelial cells were cultured in the absence or presence of IFN- 7 
(100 U/ml) for 24 h. In some cultures only phorbol-12-myristate 13-acetate was added to replace IFN- 7. The cells were then removed 
from the bottles, treated with anti-class II antibody followed by FITC-conjugated anti-mouse antibody and analysed by fluorescence 
activated cell sorter. The data are expressed as histograms, the relative fluorescence intensity is given on a logarithmic scale. 
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EC were also treated with IFN-y in combination with protein 
kinase inhibitors 1-(5-isoquinolinesulfonyl)-2-methylpiperazine 
dihydrochloride (H-7, 2-20/zM), N-(2-guanidinoethyl)-5-iso- 
quinolinesulfonamide hydrochloride (HA 1004, 20#M) and 
N-(6-aminohexyl)-5-chloro- l-naphthalenesulfonamide hydro- 
chloride (W-7, 2-30/zM) (by Seikagaku Kogyo Co., Tokyo, 
Japan) as well as with D-sphingosine (0.3 #M-3/zM; Sigma). 
Expression of class II antigens on endothelial cells was 
analysed with fluorescence activated cell sorter (FACS). The 
cells were first exposed to a monoclonal ntibody to monomor- 
phic determinant of rat class II diluted 1 : 20 (Mas 043c, Sera- 
Lab., Grawley Down, Sussex, England), washed twice and ex- 
posed to monoclonal fluorescein isothiocyanate conjugated 
anti-mouse antibody (GAM-FITC, Coulter Immunology, 
Hialeah, Florida, USA), washed twice, resuspended in 
phosphate buffered saline (PBS) and run through the FACS. 
3. RESULTS 
Only 3% of native endothelial cells expressed 
class II antigens in native state in vitro. IFN- 7 at 
a concentration f 100 U/ml for 24 h induced class 
II antigen expression on 63% of rat heart en- 
dothelial cells (fig.l, table 1). 
First we analysed which intracellular signals 
could replace the IFN-T effect in inducing class II 
molecules on the endothelial cells. Cyclic-AMP 
and -GMP were added to the endothelial cell 
cultures in a dibutyryl form, which is able to 
penetrate into the cells. Even within a wide range 
of different concentrations (from 1-1000/zM), 
cAMP or cGMP had no effect on the class II ex- 
pression, neither did the increase of cytosolic 
calcium with calcium ionophore A23187 have any 
effect (table 1). 
PMA, which belongs to phorbol esters, is a 
direct activator of protein kinase C. PMA was able 
to replace IFN- 7 in the class II expression in en- 
dothelial cell cultures (fig.l, table 1). With 1/~M 
PMA for 24 h the class II induction was half as 
strong as with 100 U/ml of IFN-y. This PMA ef- 
fect was dose-dependent: concentrations lower 
than 0.1/zM had no effect of the class II expression 
on endothelial cells. 
Since PMA also has many other biological func- 
tions than the protein kinase C stimulation, we 
confirmed the role of protein kinase C in the IFN-7 
response with specific inhibitors of protein kinase 
C. A selective nzyme inhibitor of protein kinase 
C, H-7 was added simultaneously with IFN-y to 
the endothelial cell cultures. 24 h later the class II 
antigens were analysed from these endothelial 
cells. H-7 (20/zM) totally blocked the IFN-7 induc- 
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Table 1 
Role of second messengers in regulation of class II expression 
in rat heart endothelial cells 
Treatment Class II positive 
cells (%) 
None 
IFN- 7 
PMA (aM) 
c-AMP (aM) 
c-GMP (,aM) 
Calcium ionophore (nM) 
2.8 
100 U/ml 60.7 
1 28.6 
0.5 21.0 
0.1 6.7 
1000 2.1 
100 2.4 
10 2.1 
1 2.1 
1000 2.9 
100 2.5 
10 2.6 
1 2.0 
1000 2.9 
200 1.3 
20 1.0 
ed class II upregulation (table 2, fig.2). The in- 
hibitory effect was dose-dependent; 10/zM H-7 
inhibited the class II induction half maximally and 
2/zM had no effect on the IFN-7 induced class II 
upregulation. Another enzyme inhibitor, HA 1004 
mainly inhibits protein kinase A, but also has some 
inhibitory capacity against protein kinase C. With 
this inhibitor at a concentration of 20/~M we 
blocked the IFN-7 induction of class II upregula- 
tion from 63% to 22% (table 2, fig.2). 
Shingosine is another inhibitor of protein kinase 
C, which interferes with protein kinase C activa- 
tion. 3/zM sphingosine blocked the IFN-7 induced 
class II expression from 63% to 26% (table 2, 
Table 2 
Inhibition of IFN-y induced class II expression 
IFN- 7 Inhibition Class II positive 
(100 U/ml) cells (%) 
- - 4.6 
+ - 63.2 
+ H-7 (2/zM) 28.3 
+ H-7 (10/JM) 14.0 
+ H-7 (20/~M) 5.6 
+ HA 1004 (20,uM) 21.7 
+ sphingosine (3/~M) 26.4 
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Fig.2. The effect of various protein kinase C inhibitors (H-7, 20/zM; HA 1004, 20 ,aM; sphingosine, 3/zM) on the IFN- 7 (100 U/ml) 
induced class II expression on endothelial cells. The cells were cultured with the IFN- 7 and the enzyme inhibitors for 24 h and analysed 
for class II expression. The samples were analysed as described in the legend to rigA. 
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fig.2). Higher doses of sphingosine detached the 
EC monolayers from culture bottles. Therefore it 
was not possible to analyse the effect of higher 
sphingosine concentrations. 
W-7 is a calmodulin antagonist affecting 
Ca2+-calmodulin pathway. W-7 had no effect on 
the IFN-7 induced class II induction on endothelial 
cells (not shown). 
4. DISCUSSION 
Native endothelial cells do not express class II 
antigen on their surface in vitro [1]. The induction 
of class II antigens on endothelial cells in vitro by 
IFN-7 treatment has been shown by others and us 
[1,2]. After an IFN-y (100 U/ml)  stimulus the en- 
dothelial cells begin to express class II molecules 
on their surface within 24 h, and after 72 h nearly 
all endothelial cells have class II molecules on their 
surface [10]. Our results strongly suggests that 
IFN-y upregulates the MHC class II antigens by a 
protein kinase C dependent pathway. This process 
has been shown to be dependent on both de novo 
mRNA and protein synthesis [11]. 
Very little is known so far of the postreceptor in- 
tracellular signal transduction during IFN- 7 treat- 
ment. To clarify this we applied specific inhibitors 
of protein kinase C pathway, H-7 and sphingosine. 
Both inhibited the IFN- 7 induced class II upregula- 
tion in a dose-dependent manner when added 
simultaneously with IFN- 7. These results sug- 
gested that IFN- 7 works via protein kinase C in en- 
dothelial cell class II regulation. This was further 
confirmed by PMA, which is a direct activator of 
protein kinase C [12]. PMA in a micromolar dose 
range was able to replace IFN- 7 in the induction of 
class II on endothelial cells. This dose is relatively 
high, since many other protein kinase C 
stimulatory functions of PMA operate already at 
nanomolar concentrations [13]. The need of higher 
doses may refer to the need of activation of a wider 
or a different spectrum of kinases in the protein 
kinase C family [14,15]. 
Controversial data exist concerning the signal 
transduction pathway after IFN-7 stimulation in 
transformed cell lines. IFN- 7 has been shown to 
operate via the calcium-calmodulin pathway, but 
not via protein kinase C in the HL-60 monocytic 
cell line [16]. Yet in two other monocytic ell lines, 
U 937 and in a lymphoid cell line YT-1, the protein 
kinase C pathway but not the calcium-dependent 
pathway was shown to be the route of signal 
transduction [16]. The discrepancy might be due to 
the fact that both these cell lines are malignant and 
the transformation might have caused alterations 
in the intracellular signal transduction 
mechanisms. It is also possible that IFN-7 induces 
different signal pathways in different cell types, 
but this has not yet been demonstrated in normal 
cells. 
Taken together, our results suggest that in 
cultured endothelial cells IFN- 7 operates via the 
protein kinase C pathway in the induction of class 
II expression on the endothelial cell surface. Ca 2+, 
cAMP or cGMP are not involved in this 
regulation. 
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